Journal Article

Thalidomide Treatment for Refractory HIV-Associated Colitis: A Case Series

Leann Johnson, Joseph N. Jarvis, Edmund G. L. Wilkins and Phillip E. Hay

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 47, issue 1, pages 133-136
Published in print July 2008 | ISSN: 1058-4838
Published online July 2008 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/588793
Thalidomide Treatment for Refractory HIV-Associated Colitis: A Case Series

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

Thalidomide has been used as a treatment for various human immunodeficiency virus (HIV)–associated and non–HIV-associated illnesses, generally in cases in which inflammatory disease is refractory to standard therapy. Here, we discuss the successful use of thalidomide in 3 patients with severe, idiopathic HIV-associated colitis.

Journal Article.  2075 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.